The
report by the Institute for Infectious, Helmholtz Centre (Germany)
announced on 25/5, said the agency has discovered methods of producing
the precursor of insulin (insulin precursor) with output doubled
compared to the previous .
Institute on also decided not registered patent and the entire public specifications, to help diabetes patients, especially patients in developing countries have access to many with treatment with insulin.
Currently, insulin is used in the clinical treatment mainly modulated by insulin metabolic precursors. Insulin precursor mainly produced in E. coli or Saccharomyces cerevisiae.
Based on this, scientists have discovered a new method can make money producing insulin to double production, thereby helping to lower the cost of production of insulin.
Through practical test showed that insulin is produced by the new method can be applied safely to the human body. The report said that diabetes was no longer a disease of the rich anymore.
The number of patients with diabetes in the developing countries is growing, but many patients in poor countries face many economic difficulties.
The main cause of this problem is that many new drugs and new methods have been patented invention, it makes the cost of treatment is very expensive.
The objective of the research of scientists from the Institute of Infectious, Helmholtz Centre is to lower the cost of production of insulin, which makes many diabetics benefit. /.
Institute on also decided not registered patent and the entire public specifications, to help diabetes patients, especially patients in developing countries have access to many with treatment with insulin.
Currently, insulin is used in the clinical treatment mainly modulated by insulin metabolic precursors. Insulin precursor mainly produced in E. coli or Saccharomyces cerevisiae.
Based on this, scientists have discovered a new method can make money producing insulin to double production, thereby helping to lower the cost of production of insulin.
Through practical test showed that insulin is produced by the new method can be applied safely to the human body. The report said that diabetes was no longer a disease of the rich anymore.
The number of patients with diabetes in the developing countries is growing, but many patients in poor countries face many economic difficulties.
The main cause of this problem is that many new drugs and new methods have been patented invention, it makes the cost of treatment is very expensive.
The objective of the research of scientists from the Institute of Infectious, Helmholtz Centre is to lower the cost of production of insulin, which makes many diabetics benefit. /.
0 comments:
Đăng nhận xét